Idioma:

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme

BINAGWAHO, Agnes ; WAGNER, Claire M ; GATERA, Maurice ; KAREMA, Corine ; NUTT, Cameron T ; NGABO, Fidele

Bulletin of the World Health Organization, 2012-08, Vol.90 (8), p.623-628 [Periódico revisado por pares]

Genève: Organisation mondiale de la santé

Texto completo disponível

Citações Citado por

Enviar para

Título:
Achieving high coverage in Rwanda's national human papillomavirus vaccination programme
Autor: BINAGWAHO, Agnes ; WAGNER, Claire M ; GATERA, Maurice ; KAREMA, Corine ; NUTT, Cameron T ; NGABO, Fidele
Assuntos: Adolescent ; Adult ; Biological and medical sciences ; Cancer ; Cervical cancer ; Communities ; Developing countries ; Disease prevention ; Education ; Female ; First ladies ; General aspects ; Girls ; Health ; Health care ; Health Policy & Services ; Human ; Human papillomavirus ; Humans ; Immunization ; Immunization Programs - organization & administration ; Immunization Programs - statistics & numerical data ; Infectious diseases ; LDCs ; Lessons from the Field ; Low income groups ; Medical sciences ; Medical screening ; Miscellaneous ; Mortality ; Papillomaviridae ; Papillomavirus Vaccines - administration & dosage ; Partnerships ; Prevention and actions ; Public health ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Public-Private Sector Partnerships ; Rwanda ; Uterine Cervical Neoplasms - prevention & control ; Vaccines ; Womens health ; Workers ; Working groups ; Young Adult
É parte de: Bulletin of the World Health Organization, 2012-08, Vol.90 (8), p.623-628
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Virtually all women who have cervical cancer are infected with the human papillomavirus (HPV). Of the 275,000 women who die from cervical cancer every year, 88% live in developing countries. Two vaccines against the HPV have been approved. However, vaccine implementation in low-income countries tends to lag behind implementation in high-income countries by 15 to 20 years. In 2011, Rwanda's Ministry of Health partnered with Merck to offer the Gardasil HPV vaccine to all girls of appropriate age. The Ministry formed a "public-private community partnership" to ensure effective and equitable delivery. Thanks to a strong national focus on health systems strengthening, more than 90% of all Rwandan infants aged 12-23 months receive all basic immunizations recommended by the World Health Organization. In 2011, Rwanda's HPV vaccination programme achieved 93.23% coverage after the first three-dose course of vaccination among girls in grade six. This was made possible through school-based vaccination and community involvement in identifying girls absent from or not enrolled in school. A nationwide sensitization campaign preceded delivery of the first dose. Through a series of innovative partnerships, Rwanda reduced the historical two-decade gap in vaccine introduction between high- and low-income countries to just five years. High coverage rates were achieved due to a delivery strategy that built on Rwanda's strong vaccination system and human resources framework. Following the GAVI Alliance's decision to begin financing HPV vaccination, Rwanda's example should motivate other countries to explore universal HPV vaccine coverage, although implementation must be tailored to the local context.
Editor: Genève: Organisation mondiale de la santé
Idioma: Inglês;Português

Links

Voltar para lista de resultados

Anterior Resultado 11 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme

BINAGWAHO, Agnes ; WAGNER, Claire M ; GATERA, Maurice ; KAREMA, Corine ; NUTT, Cameron T ; NGABO, Fidele

Genève: Organisation mondiale de la santé

Buscando em bases de dados remotas. Favor aguardar.